Skip to main content
Caplight Logo









AIBODY

AIBODY

Private
LondonHealthcare & Life Scienceshttps://aibody.io/

Last Round

Seed

Mar 18, 2021

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AIBODY is a healthcare technology company that provides a cloud-based digital physiology platform for medical education, clinical training, and research through high-fidelity human body simulations.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Synthetic Data, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

physiological simulationvirtual patientdigital twinmedical simulationclinical trainingsynthetic datapharmacological simulationmedical educationdrug discoveryhealthcare analyticsSaaSB2B healthcarevirtual clinical trialsin silico medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AIBODY Comparables

Compare AIBODY with similar companies based on industry and business-model similarity.

AIBODY comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HC Simulation, LLC
82%
Mantis Biotechnology
78%
Computational Life
78%

AIBODY Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 18, 2021

Key People

Founding team and executive leadership

Oleksandr Mokin

Chief Technology Officer

Executive Team

AIBODY Investors

Notable investors and investment history

AIBODY investors
InvestorRounds
Raw VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 41% MoM, reaching 2.6K.

  • Jun 1, 2025

    Monthly visitors increased 53% MoM, reaching 2.9K.

AIBODY Filings

Explore SEC and related filing metadata, where available.

AIBODY filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AIBODY's valuation, stock price, and market status.

Is AIBODY a public or private company?

AIBODY is a private company.

What is the current stock price of AIBODY?

AIBODY is a private company with no public stock price. No recent secondary market data is available.

How much is AIBODY worth (valuation)?

Valuation information for AIBODY is not publicly available.

Can I buy AIBODY stock?

AIBODY shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AIBODY's last funding round?

AIBODY's most recent funding round was Seed on March 18, 2021.

Who are the main investors in AIBODY?

Key investors in AIBODY include Raw Ventures.

Will AIBODY IPO soon?

No public IPO plans have been announced for AIBODY.

How can I track AIBODY secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AIBODY's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range24
Year Founded2020
Last FundingMar 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?